This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Apr 25;380(17):1678.

doi: 10.1056/NEJMc1902165.

Cardiovascular Risk Reduction with Icosapent Ethyl. Reply

Deepak L Bhatt¹, P Gabriel Steg², Michael Miller³

Affiliations

Affiliations

¹ Brigham and Women's Hospital, Boston, MA dlbhattmd@post.harvard.edu.
² Assistance Publique-Hôpitaux de Paris, Paris, France.
³ University of Maryland School of Medicine, Baltimore, MD.

PMID: 31018077
DOI: 10.1056/NEJMc1902165

Comment

Cardiovascular Risk Reduction with Icosapent Ethyl. Reply

Deepak L Bhatt et al. N Engl J Med. 2019.

. 2019 Apr 25;380(17):1678.

doi: 10.1056/NEJMc1902165.

Authors

Deepak L Bhatt¹, P Gabriel Steg², Michael Miller³

Affiliations

¹ Brigham and Women's Hospital, Boston, MA dlbhattmd@post.harvard.edu.
² Assistance Publique-Hôpitaux de Paris, Paris, France.
³ University of Maryland School of Medicine, Baltimore, MD.

PMID: 31018077
DOI: 10.1056/NEJMc1902165

No abstract available

PubMed Disclaimer

Comment in

Novel antibody-based reversal agent for ticagrelor.
Huynh K. Huynh K. Nat Rev Cardiol. 2019 Jun;16(6):320-321. doi: 10.1038/s41569-019-0191-4. Nat Rev Cardiol. 2019. PMID: 30926907 No abstract available.

Comment on

Cardiovascular Risk Reduction with Icosapent Ethyl.
Chan LN. Chan LN. N Engl J Med. 2019 Apr 25;380(17):1677. doi: 10.1056/NEJMc1902165. N Engl J Med. 2019. PMID: 31018075 No abstract available.
Cardiovascular Risk Reduction with Icosapent Ethyl.
Borghi C, Fogacci F, Cicero AFG. Borghi C, et al. N Engl J Med. 2019 Apr 25;380(17):1678. doi: 10.1056/NEJMc1902165. N Engl J Med. 2019. PMID: 31018076 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information